fbpx Skip to main content

Member's Profile

CytomX Therapeutics

Location
151 Oyster Point Blvd. Suite 400
South San Francisco,   CA
94080
United States
Sector
Biotech
Membership Info
Membership Type: Industry
Membership Since: 2015
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About CytomX Therapeutics
Biotech Company
CytomX Therapeutics is a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform. Probody therapeutics are designed to exploit unique conditions of the tumor microenvironment to more effectively localize antibody binding and activity while minimizing activity in healthy tissues. CytomX and its partners have four programs in the clinic. The Company's clinical stage pipeline includes cancer immunotherapies against clinically-validated targets, including a PD-L1-targeting Probody therapeutic wholly owned by CytomX (CX-072) and a CTLA-4-targeting Probody therapeutic partnered with Bristol Myers...
Related News
No related news posted by this Member